40% af patienterne havde behov for en glipiziddosis på ≤5 mg/ dag i hele undersøgelsesperioden.
The mean glipizide dose used in the comparator group was 10 mg per day with approximately 40% of patients requiring a glipizide dose of ≤ 5 mg/ day throughout the study.